Kirby Institute

prep_pic.jpg

A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.

bigstock-blue-pills-falling-101429951_1.jpg

New reports released today show that increases in government funding for prevention strategies are achieving significant reductions in the risk of HIV transmission.

28_hepatitis_c.jpg

Researchers from the Kirby Institute say its time to remove restrictions that prevent recent drug users from accessing successful hepatitis C treatment.

shutterstock_217398805.jpg

Point-of-care tests to detect and treat key infectious diseases will be expanded in 300 health centres in four countries thanks to a new program led by UNSW. 

shutterstock_160438778.jpg

Newly released data from the Kirby Institute show a decline in the uptake of life-saving treatments among people living with hepatitis C.

world_in_hands_original_002.jpg

New research from NDARC and the Kirby Institute at UNSW Sydney shows almost 40% of people who have injected drugs in the past year are living with hepatitis C.

26_hiv_shutterstock.jpg

A study led by the Kirby Institute at UNSW supports evidence that treatment-as-prevention allows people living with HIV to have effectively zero chance of sexually transmitting the virus to others.

_18a1559.jpg

A symposium of distinguished guests supported a research agenda to perpetuate the legacy of the late Professor David Cooper. 

_a2a9808.jpg

Hundreds of people gathered at Sydney's Town Hall today to remember UNSW Scientia Professor David Cooper AC, immunologist and pioneer in the fight against HIV/AIDS.

flu vaccine.jpg

Researchers at the Kirby Institute and UNSW Sydney have found that due to a decrease in the effectiveness of the flu vaccine over time, June and July could be the best time to get the jab for overall protection against the illness. 

Pages